Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | INSM |
---|---|---|
09:32 ET | 10098 | 72.93 |
09:33 ET | 2354 | 72.52 |
09:35 ET | 7813 | 71.91 |
09:37 ET | 7018 | 71.83 |
09:39 ET | 1600 | 71.69 |
09:42 ET | 1745 | 71.725 |
09:44 ET | 2489 | 71.71 |
09:46 ET | 500 | 71.74 |
09:48 ET | 300 | 71.935 |
09:50 ET | 1013 | 71.96 |
09:51 ET | 2208 | 71.99 |
09:53 ET | 2076 | 71.89 |
09:55 ET | 2401 | 71.65 |
09:57 ET | 748 | 71.73 |
10:00 ET | 2300 | 71.76 |
10:02 ET | 33001 | 71.31 |
10:04 ET | 3696 | 71.19 |
10:06 ET | 7567 | 71.17 |
10:08 ET | 5300 | 71.3025 |
10:09 ET | 6654 | 71.1978 |
10:11 ET | 436 | 71.35 |
10:13 ET | 587 | 71.36 |
10:15 ET | 1376 | 71.59 |
10:18 ET | 1744 | 71.82 |
10:20 ET | 400 | 71.98 |
10:22 ET | 314 | 71.87 |
10:24 ET | 1038 | 71.7 |
10:26 ET | 1900 | 71.75 |
10:27 ET | 992 | 71.735 |
10:29 ET | 500 | 71.58 |
10:31 ET | 3293 | 71.59 |
10:33 ET | 1084 | 71.585 |
10:36 ET | 1697 | 71.74 |
10:38 ET | 5092 | 71.6 |
10:40 ET | 2300 | 71.5 |
10:42 ET | 3410 | 71.51 |
10:44 ET | 1900 | 71.655 |
10:45 ET | 961 | 71.52 |
10:47 ET | 2702 | 71.7 |
10:49 ET | 1200 | 71.715 |
10:51 ET | 600 | 71.785 |
10:54 ET | 1740 | 71.72 |
10:56 ET | 4826 | 72.01 |
10:58 ET | 4952 | 72 |
11:00 ET | 1900 | 71.945 |
11:02 ET | 12607 | 71.95 |
11:03 ET | 323 | 71.935 |
11:05 ET | 500 | 71.79 |
11:07 ET | 2301 | 71.765 |
11:09 ET | 985 | 71.645 |
11:12 ET | 2400 | 71.67 |
11:14 ET | 2356 | 71.82 |
11:16 ET | 21852 | 71.935 |
11:18 ET | 5369 | 71.89 |
11:20 ET | 2548 | 71.8 |
11:21 ET | 700 | 71.56 |
11:23 ET | 1400 | 71.555 |
11:25 ET | 3177 | 71.79 |
11:27 ET | 1316 | 71.92 |
11:30 ET | 755 | 71.845 |
11:32 ET | 2519 | 71.88 |
11:34 ET | 2500 | 71.79 |
11:36 ET | 10150 | 71.9 |
11:38 ET | 3886 | 71.87 |
11:39 ET | 600 | 71.8 |
11:41 ET | 1200 | 71.77 |
11:43 ET | 800 | 71.745 |
11:45 ET | 2200 | 71.81 |
11:48 ET | 445 | 71.75 |
11:50 ET | 2000 | 71.78 |
11:52 ET | 6713 | 71.93 |
11:54 ET | 15900 | 72.1593 |
11:56 ET | 8102 | 72.57 |
11:57 ET | 256 | 72.51 |
11:59 ET | 201 | 72.53 |
12:01 ET | 700 | 72.48 |
12:03 ET | 2617 | 72.66 |
12:06 ET | 326 | 72.595 |
12:08 ET | 3099 | 72.69 |
12:10 ET | 2005 | 72.81 |
12:12 ET | 263 | 72.81 |
12:14 ET | 500 | 72.86 |
12:15 ET | 1583 | 72.87 |
12:17 ET | 200 | 72.84 |
12:19 ET | 4204 | 72.86 |
12:21 ET | 2362 | 73.02 |
12:24 ET | 549 | 72.93 |
12:26 ET | 472 | 72.9 |
12:28 ET | 537 | 72.87 |
12:30 ET | 2439 | 73.05 |
12:32 ET | 1660 | 73.04 |
12:33 ET | 771 | 73 |
12:35 ET | 300 | 73.02 |
12:37 ET | 1200 | 72.895 |
12:39 ET | 630 | 72.93 |
12:42 ET | 1992 | 73.08 |
12:44 ET | 3950 | 73.15 |
12:46 ET | 1950 | 73.155 |
12:48 ET | 2423 | 73.26 |
12:50 ET | 2300 | 73.19 |
12:51 ET | 774 | 73.18 |
12:53 ET | 1573 | 73.23 |
12:55 ET | 800 | 73.32 |
12:57 ET | 1600 | 73.24 |
01:00 ET | 834 | 73.205 |
01:02 ET | 400 | 73.21 |
01:04 ET | 2496 | 73.2301 |
01:06 ET | 300 | 73.23 |
01:08 ET | 1162 | 73.1212 |
01:09 ET | 1976 | 73.24 |
01:11 ET | 1472 | 73.27 |
01:13 ET | 100 | 73.22 |
01:15 ET | 1110 | 73.215 |
01:18 ET | 2996 | 73.08 |
01:20 ET | 400 | 73.06 |
01:22 ET | 811 | 73.04 |
01:24 ET | 4267 | 73.145 |
01:26 ET | 2701 | 73.26 |
01:27 ET | 429 | 73.22 |
01:29 ET | 1600 | 73.06 |
01:31 ET | 3069 | 73.18 |
01:33 ET | 1402 | 73.025 |
01:36 ET | 300 | 72.96 |
01:38 ET | 300 | 72.96 |
01:40 ET | 2579 | 72.79 |
01:42 ET | 2000 | 72.82 |
01:44 ET | 200 | 72.83 |
01:45 ET | 1212 | 72.875 |
01:47 ET | 1000 | 72.79 |
01:49 ET | 3752 | 72.79 |
01:51 ET | 200 | 72.75 |
01:54 ET | 400 | 72.81 |
01:56 ET | 3206 | 72.845 |
01:58 ET | 1200 | 72.9 |
02:00 ET | 3224 | 73.05 |
02:02 ET | 884 | 73.12 |
02:03 ET | 453 | 72.99 |
02:05 ET | 763 | 72.96 |
02:07 ET | 1846 | 72.85 |
02:09 ET | 2368 | 72.88 |
02:12 ET | 7539 | 73.03 |
02:14 ET | 9443 | 73.02 |
02:16 ET | 750 | 73.08 |
02:18 ET | 1953 | 73.125 |
02:20 ET | 3824 | 73.25 |
02:21 ET | 3655 | 73.21 |
02:23 ET | 5359 | 73.65 |
02:25 ET | 400 | 73.595 |
02:27 ET | 1200 | 73.65 |
02:30 ET | 2734 | 73.485 |
02:32 ET | 1650 | 73.45 |
02:34 ET | 17734 | 73.65 |
02:36 ET | 800 | 73.71 |
02:38 ET | 5034 | 73.8 |
02:39 ET | 1244 | 73.78 |
02:41 ET | 2888 | 73.77 |
02:43 ET | 1656 | 73.6525 |
02:45 ET | 22700 | 73.76 |
02:48 ET | 1350 | 73.73 |
02:50 ET | 3648 | 73.5 |
02:52 ET | 1136 | 73.48 |
02:54 ET | 2274 | 73.47 |
02:56 ET | 2500 | 73.41 |
02:57 ET | 1448 | 73.46 |
02:59 ET | 8676 | 73.52 |
03:01 ET | 700 | 73.47 |
03:03 ET | 1848 | 73.4825 |
03:06 ET | 1678 | 73.53 |
03:08 ET | 1800 | 73.68 |
03:10 ET | 1823 | 73.74 |
03:12 ET | 5384 | 73.9 |
03:14 ET | 17879 | 73.97 |
03:15 ET | 2204 | 73.965 |
03:17 ET | 4389 | 74 |
03:19 ET | 4472 | 73.825 |
03:21 ET | 4200 | 73.82 |
03:24 ET | 993 | 73.78 |
03:26 ET | 1559 | 73.67 |
03:28 ET | 1104 | 73.79 |
03:30 ET | 3380 | 73.71 |
03:32 ET | 1800 | 73.51 |
03:33 ET | 2554 | 73.49 |
03:35 ET | 4946 | 73.38 |
03:37 ET | 5215 | 73.37 |
03:39 ET | 14081 | 73.52 |
03:42 ET | 3500 | 73.58 |
03:44 ET | 9555 | 73.455 |
03:46 ET | 4781 | 73.515 |
03:48 ET | 36885 | 73.5 |
03:50 ET | 15109 | 73.48 |
03:51 ET | 12388 | 73.595 |
03:53 ET | 22594 | 73.74 |
03:55 ET | 8782 | 73.74 |
03:57 ET | 36510 | 73.7 |
04:00 ET | 258142 | 73.81 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Insmed Inc | 13.2B | -13.3x | --- |
Summit Therapeutics Inc | 13.6B | -66.5x | --- |
Vaxcyte Inc | 11.0B | -19.4x | --- |
Intra-Cellular Therapies Inc | 9.1B | -99.4x | --- |
Revolution Medicines Inc | 9.6B | -15.8x | --- |
Ascendis Pharma A/S | 7.4B | -15.7x | --- |
Insmed Incorporated is a global biopharmaceutical company. The Company's first commercial product, ARIKAYCE (amikacin liposome inhalation suspension), is used for the treatment of Mycobacterium avium complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. Its pipeline includes clinical-stage programs, brensocatib and TPIP, as well as other early-stage research programs. Brensocatib is a small molecule, oral, reversible inhibitor of dipeptidyl peptidase 1 (DPP1), which is developing for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases, including chronic rhinosinusitis without nasal polyps (CRSsNP). TPIP is an inhaled formulation of the treprostinil prodrug treprostinil palmitil, which offers a differentiated product profile for pulmonary hypertension associated with interstitial lung disease (PH-ILD) and pulmonary arterial hypertension (PAH).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $13.2B |
---|---|
Revenue (TTM) | $343.0M |
Shares Outstanding | 178.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.10 |
EPS | $-5.56 |
Book Value | $-2.24 |
P/E Ratio | -13.3x |
Price/Sales (TTM) | 38.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -240.88% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.